docetaxel anhydrous has been researched along with Liver Dysfunction in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, J; Liu, G; Liu, J; Wu, J; Xin, P | 1 |
| Booser, DJ; Eckmann, K; Esparza-Guerra, L; Green, MC; Hortobagyi, GN; Kawedia, J; Madden, TL; Michaud, LB; Rivera, E; Valero, V | 1 |
| Chan, D; Chuah, B; Goh, BC; Lee, SC; Soe, MY; Soo, RA; Syn, NL; Tan, SH; Wang, L; Wong, AL; Yong, WP | 1 |
| Fujii, H; Igarashi, T; Itoh, K; Kawada, K; Minami, H; Ozawa, K; Saeki, T; Sasaki, Y; Sato, H; Tahara, M | 1 |
| Minami, H; Ozawa, K; Sato, H | 1 |
| Kita, K; Kubota, Y; Makiyama, K; Miyake, M; Murakami, T; Nakaigawa, N; Ogawa, T; Sano, F; Terao, H; Uemura, H; Yanagisawa, M; Yao, M | 1 |
| Clarke, SJ; Rivory, LP | 1 |
| Blesch, K; Reigner, B; Weidekamm, E | 1 |
| Samur, M | 1 |
3 review(s) available for docetaxel anhydrous and Liver Dysfunction
| Article | Year |
|---|---|
Biomedical applications of methionine-based systems.
Topics: Cell Proliferation; COVID-19; COVID-19 Drug Treatment; Docetaxel; Humans; Liver Diseases; Methionine; Nanoparticles; Neoplasms; S-Adenosylmethionine; SARS-CoV-2 | 2021 |
Clinical pharmacokinetics of docetaxel.
Topics: Animals; Antineoplastic Agents, Phytogenic; Child; Clinical Trials as Topic; Docetaxel; Drug Interactions; Forecasting; Humans; Kidney Diseases; Liver Diseases; Paclitaxel; Protein Binding; Taxoids | 1999 |
Clinical pharmacokinetics of capecitabine.
Topics: Antacids; Antimetabolites, Antineoplastic; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Drug Interactions; Fluorouracil; Food; Humans; Intestinal Absorption; Leucovorin; Liver Diseases; Paclitaxel; Protein Binding; Taxoids | 2001 |
2 trial(s) available for docetaxel anhydrous and Liver Dysfunction
| Article | Year |
|---|---|
Dose modifications in Asian cancer patients with hepatic dysfunction receiving weekly docetaxel: A prospective pharmacokinetic and safety study.
Topics: Adult; Aged; Antineoplastic Agents; Area Under Curve; Asian People; Docetaxel; Dose-Response Relationship, Drug; Female; Humans; Liver; Liver Diseases; Male; Middle Aged; Neoplasms; ROC Curve; Taxoids | 2016 |
Clinical trial simulations for dosage optimization of docetaxel in patients with liver dysfunction, based on a log-binominal regression for febrile neutropenia.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Docetaxel; Feasibility Studies; Fever; Humans; Infusions, Intravenous; Liver Diseases; Lung Neoplasms; Metabolic Clearance Rate; Monte Carlo Method; Neutropenia; Taxoids | 2009 |
4 other study(ies) available for docetaxel anhydrous and Liver Dysfunction
| Article | Year |
|---|---|
Pilot study to assess toxicity and pharmacokinetics of docetaxel in patients with metastatic breast cancer and impaired liver function secondary to hepatic metastases.
Topics: Adult; Aged; Breast Neoplasms; Docetaxel; Female; Humans; Liver; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Pilot Projects; Taxoids | 2014 |
Population pharmacokinetics of docetaxel in patients with hepatic dysfunction treated in an oncology practice.
Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Antineoplastic Agents; Aspartate Aminotransferases; Docetaxel; Female; Humans; Liver Diseases; Male; Middle Aged; Neoplasms; Taxoids | 2009 |
[Chemotherapy with low-dose docetaxel and estramustine phosphate in patient with liver dysfunction due to liver metastases of hormone-refractory prostate cancer : a case report].
Topics: Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Estramustine; Humans; Liver Diseases; Liver Neoplasms; Male; Prostatic Neoplasms; Taxoids | 2010 |
Docetaxel and liver dysfunction: is it absolutely contraindicated?
Topics: Antineoplastic Agents, Phytogenic; Contraindications; Docetaxel; Female; Humans; Liver Diseases; Middle Aged; Paclitaxel; Taxoids | 2001 |